Skip to main content
TipRanks
Go Ultimate75% OFF

Kura Oncology (KURA) Ownership - Who Owns Kura Oncology?

974 Followers

Kura Oncology (KURA) Ownership Overview

  • 2.59% Insiders
  • 11.05% Mutual Funds
  • 47.29% Other Institutional Investors
  • 16.36% ETFs
  • 22.70% Public Companies and Individual Investors

The ownership structure of Kura Oncology (KURA) stock is a mix of institutional, retail, and individual investors. Approximately 74.70% of the company’s stock is owned by Institutional Investors, 2.59% is owned by Insiders, and 22.70% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Nov 15, 2026Troy Edward Wilson$1,504,765
Sep 28, 2026Kathleen Ford$72,444
Sep 28, 2026Teresa Brophy Bair$88,557
Sep 28, 2026Mollie Leoni$130,580

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026Woodline Partners Lp$2,824,270
Sep 30, 2026 $125,938,665
Sep 30, 2026Entrypoint Capital, Llc$121,537
Sep 30, 2026Fisher Asset Management Llc$6,054,363

Top Shareholders

KURA top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.11,758,979Institution12.80%83,371,161
Ishares4,706,859Institution5.12%33,371,630
Vanguard4,636,230Institution5.05%32,870,871
Vanguard Index Funds3,826,281Institution4.16%27,128,332
Spdr2,966,630Institution3.23%21,033,407
Troy Edward Wilson1,414,650Insider1.54%10,029,869
Fidelity Salem Street Trust1,022,335Institution1.11%7,248,355
Fidelity Concord Street Trust884,005Institution0.96%6,267,595
Chuck Royce658,811Institution0.72%4,670,970
Blackrock Funds653,639Institution0.71%4,634,301

Top Mutual Fund Holders

KURA top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds3,826,281Institution4.16%27,128,332
Fidelity Salem Street Trust1,022,335Institution1.11%7,248,355
Fidelity Concord Street Trust884,005Institution0.96%6,267,595
Blackrock Funds653,639Institution0.71%4,634,301
Dfa Investment Dimensions Group Inc592,987Institution0.65%4,204,278
Vanguard Scottsdale Funds588,069Institution0.64%4,169,409
Tiaa-cref Funds301,598Institution0.33%2,138,330
Vanguard Horizon Funds300,321Institution0.33%2,129,276
Vanguard Explorer Fund245,051Institution0.27%1,737,412
Exchange Place Advisors Trust240,434Institution0.26%1,704,677

Top ETF Holders

KURA top ETF holders
Holder# of SharesType% HoldingValue
SPDR S&P BIOTECH ETF, XBI ETF2,665,590Institution2.90%20,711,634
iShares Russell 2000 ETF, IWM ETF2,222,434Institution2.42%17,268,312
Vanguard Total Stock Market ETF, VTI ETF2,115,003Institution2.30%21,699,931
Vanguard Extended Market ETF, VXF ETF1,022,231Institution1.11%10,488,090
iShares Russell 2000 Growth ETF, IWO ETF796,345Institution0.87%6,187,601
iShares Biotechnology ETF, IBB ETF668,814Institution0.73%4,741,891
Fidelity Enhanced Small Cap ETF, FESM ETF550,202Institution0.60%4,275,070
Vanguard Russell 2000 ETF, VTWO ETF500,771Institution0.55%5,137,910
Schwab U.S. Small-Cap ETF, SCHA ETF477,091Institution0.52%3,706,997
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund, IDNA ETF267,028Institution0.29%1,893,229

FAQ

Who Owns Kura Oncology (KURA)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 74.70% of the company's stock is held by institutional investors, 2.59% is held by insiders, and 22.70% is held by public companies and individual investors.
What percentage of Kura Oncology (KURA) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 74.70% of Kura Oncology (KURA) stock is held by institutional investors: 11.05% by mutual funds, 16.36% by ETFs and 47.29% by other institutional investors.
What percentage of Kura Oncology (KURA) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 22.70% of Kura Oncology (KURA) stock is held by public companies and individual investors.
Who owns the most shares of Kura Oncology (KURA)?
BlackRock, Inc. owns the most shares of Kura Oncology (KURA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.